Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirsty L Richardson

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 24, 2020
Direct in vivo comparison of [<sup>18</sup>F]PSMA-1007 with [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]AlF-PSMA-11 in mice bearing PSMA-expressing xenograftsJoseph A Ioppolo, Rikki A Nezich, Kirsty L Richardson, et al.
Frontiers in Oncology|April 25, 2020
Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and ImmunologyRikki A M Brown, Kirsty L Richardson, Tasnuva D Kabir, et al.
BMC Biotechnology|March 18, 2018
Total RNA extraction from tissues for microRNA and target gene expression analysis: not all kits are created equalRikki A M Brown, Michael R Epis, Jessica L Horsham, et al.
Scientific Reports|September 10, 2021
The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancerDianne J Beveridge, Kirsty L Richardson, Michael R Epis, et al.
Scientific Reports|October 21, 2025
PACT is requisite for prostate cancer cell proliferationDianne J Beveridge, Andrew J Woo, Kirsty L Richardson, et al.
Kidney International|August 18, 2019
Genetic characterization of early renal changes in a novel mouse model of diabetic kidney diseaseLois A Balmer, Rhiannon Whiting, Caroline Rudnicka, et al.
Oncotarget|September 15, 2017
miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progressionMichael R Epis, Keith M Giles, Dianne J Beveridge, et al.
International Journal of Molecular Sciences|May 14, 2025
MicroRNA-142-3p Overcomes Drug Resistance in Hepatocellular Carcinoma by Targeting YES1 and TWF1Khadijeh Mahboobnia, Tasnuva D Kabir, Rui Hou, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 1, 2017
Evaluation of MicroRNA Delivery In VivoRikki A M Brown, Kirsty L Richardson, Felicity C Kalinowski, et al.
Hepatology (Baltimore, Md.)|August 24, 2017
A microRNA-7/growth arrest specific 6/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinomaTasnuva D Kabir, Clarissa Ganda, Rikki M Brown, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 24, 2020
Direct in vivo comparison of [<sup>18</sup>F]PSMA-1007 with [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]AlF-PSMA-11 in mice bearing PSMA-expressing xenograftsJoseph A Ioppolo, Rikki A Nezich, Kirsty L Richardson, et al.
Frontiers in Oncology|April 25, 2020
Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and ImmunologyRikki A M Brown, Kirsty L Richardson, Tasnuva D Kabir, et al.
BMC Biotechnology|March 18, 2018
Total RNA extraction from tissues for microRNA and target gene expression analysis: not all kits are created equalRikki A M Brown, Michael R Epis, Jessica L Horsham, et al.
Scientific Reports|September 10, 2021
The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancerDianne J Beveridge, Kirsty L Richardson, Michael R Epis, et al.
Scientific Reports|October 21, 2025
PACT is requisite for prostate cancer cell proliferationDianne J Beveridge, Andrew J Woo, Kirsty L Richardson, et al.
Kidney International|August 18, 2019
Genetic characterization of early renal changes in a novel mouse model of diabetic kidney diseaseLois A Balmer, Rhiannon Whiting, Caroline Rudnicka, et al.
Oncotarget|September 15, 2017
miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progressionMichael R Epis, Keith M Giles, Dianne J Beveridge, et al.
International Journal of Molecular Sciences|May 14, 2025
MicroRNA-142-3p Overcomes Drug Resistance in Hepatocellular Carcinoma by Targeting YES1 and TWF1Khadijeh Mahboobnia, Tasnuva D Kabir, Rui Hou, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 1, 2017
Evaluation of MicroRNA Delivery In VivoRikki A M Brown, Kirsty L Richardson, Felicity C Kalinowski, et al.
Hepatology (Baltimore, Md.)|August 24, 2017
A microRNA-7/growth arrest specific 6/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinomaTasnuva D Kabir, Clarissa Ganda, Rikki M Brown, et al.
Pageof 2